GBT Enters Into a Sales Agreement with Med Tech/Med Care Associates

NAPLES, FL – August 19, 2019 – Global Biomedical Technologies (GBT), an emerging MedTech company that has developed and commercialized the world’s first switchable smart medical adhesive product platform, announced that it has entered into a definitive agreement with MTMC Associates to promote its Comfort Release® portfolio. MTMC is the healthcare industry’s largest independent sales force with more than 100 sales executives representing all of North America, including Alaska, Hawaii, and the Caribbean.

This partnership will strengthens GBT’s position primarily in long term care, home health, and DMSs, and secondarily in acute care, alternate care, surgery centers, post-acute care, and point of care segments and will deliver meaningful value to MTMC and GBT customers. It also provides new opportunities for GBT to be in collaboration with a much larger field-based organization like MTMC, during a product launch-acceleration program planned for Q4 2019.

“We believe MTMC is an ideal partner and view this collaboration as a strategic fit that will generate many benefits for our customers and their patients.  The addition of our complementary technologies to their portfolio will allow us to collectively bring more value to the healthcare providers across the acute and post-acute segments MTMC serves,” said Howard Rosing, MD, PhD, President of GBT.

About GBT
GBT is an emerging MedTech company leading the advancement of Comfort Release®, the first medical adhesive platform for acute and advanced wound care which can function on-command to optimally adhere and release pain-free which can improve patients’ comfort level during the healing process and prevent removal skin tears post-healing. For more information, visit www.comfortrelease.com.

About MTMC
MTMC, with offices in Forestdale, MA, is a nationally recognized outsourced sales organization that provides an exemplary nationwide independent sales team solution, meeting the emerging needs of leading healthcare manufacturers for more than 30 years. For more information, visit www.medtechmedcare.com.


        LEARN MORE       

August 29th, 2019|Comments Off on GBT Enters Into a Sales Agreement with Med Tech/Med Care Associates

Global Biomedical and Lewis Drug Announce Their Partnership

Lewis Drug and Global Biomedical Announce Partnership to Begin Offering the Comfort Release® Platform in Its Locations

February 13, 2019 10:32 AM EST / NAPLES, FL—Global Biomedical Technologies (GBT), an emerging MedTech company that has developed the world’s first switchable smart medical adhesive product platform, and Lewis Drug, the 56 store neighborhood pharmacy spanning across South Dakota, Iowa, and Minnesota, announced their partnership today to integrate the Comfort Release® platform into its pharmacy locations in February 2019.

The affiliation between the two companies will provide Lewis Drug customers with a new portfolio of pain-free medical adhesive products for sensitive skin wound management, starting with acute care bandages and transparent tape, and will continue to expand the portfolio resource throughout the year to include advanced options such as foam and transparent dressings. The new platform integrates smoothly into the pharmacy’s current acute care offerings by expanding and simplifying the process of managing sensitive skin based wounds for seniors and children, which ultimately benefits both pharmacies, patients, and providers.

“The addition of the Comfort Release® platform has really streamlined a continuum of care process of assisting patients with managing their wounds along with their sensitive skin needs. It has also been extremely helpful when trying to find a cost-effective alternative for certain medical bandages and tapes that are not completely pain-free at the time of removal,” said Troy Claussen, Category Manager at Lewis Drug.

Lewis Drug and GBT both take pride in offering superior customer quality of care and the accessibility to new innovations that will help patients improve healing and ultimately save money.

The partnership with GBT will add to Lewis Drug’s existing portfolio of acute care product options available to assist its retail customers. “We are honored to work with Lewis Drug to bring to market a unique and best in class smart medical adhesive portfolio that will forever change the way sensitive skin based wounds are treated,” said Dr. Howard Rosing, President and CEO of GBT. “This is a critical time in healthcare as we face an ever-rising population of seniors combined with an anticipated boom in America’s birth rate, and we can use innovation to give pharmacies a tremendous advantage every day.”

About Lewis Drug
Lewis Drug has been the first stop community pharmacy with locations spanning South Dakota, Iowa, and Minnesota for the past 76 years. The 56 store community pharmacy and market leader is committed to providing a range of outstanding pharmacy services, friendly customer service, and exceptional prices. For more information, visit www.lewisdrug.com

About Global Biomedical Technologies
GBT is an emerging MedTech company leading the advancement of a smart medical adhesive platform for acute and advanced wound care that intelligently can function to optimally adhere and release pain-free on command which can improve patients’ comfort level during the healing experience. For more information, visit www.comfortrelease.com

GBT / TJ Douglas, 470-636-4410

February 13th, 2019|Comments Off on Global Biomedical and Lewis Drug Announce Their Partnership

Comfort Release® Bandages Now Available to the Public

Comfort Release ProductsCheered by moms, doctors and nurses, Comfort Release® bandages and adhesive tapes are putting smiles on the faces of patients and caregivers.

Invented by Howard Rosing* MD, PhD, Comfort Release® uses a patented technology that sticks when you need it and releases when you don’t.

Comfort Release® is a product developed by Global Biomedical Technologies to transform the medical bandage industry in the way wounds are treated now and into the future.

Global Biomedical Technologies president Rosing stated, “I expect this product to revolutionize the bandage industry because of the ease of use, the simplicity and practicality of the way the adhesive works to bring comfort and safety to the patient and user. It won’t re-open old wounds like traditional bandages.”

Each year, there are 1.5 million skin injuries associated with adhesive bandage removal in the U.S. alone. Dr. Rosing created the unique adhesive in response to a call from the medical community for bandaging that covers wounds, sticks well when you want it to and doesn’t adversely impact wounds when the bandage or tape is removed. Unlike traditional bandages that often remove hair and even skin along with the bandage, Comfort Release® bandages and tapes come off easily with no pain or discomfort.

Comfort Release® bandages and tapes are recommended by doctors and nurses for people with sensitive skin, thin skin, fragile skin, skin that bruises easily or anyone on medications.

And it’s not just the medical community that is giving this new product rave reviews. In test trials, moms overwhelmingly preferred affordable Comfort Release bandages because the bandages stay in place during normal bathing and physical activity, yet release gently when removed.

See the clinical studies and testimonials for results.

Comfort Release® instructional videos and testimonials
Clinical Evaluations
Research Papers

*Howard Rosing, MD, PHD, is president and CEO of Global Biomedical Technologies

Website: https://comfortrelease.com
Contact: info@comfortrelease.com
(o): 470-636-4410

November 8th, 2018|Comments Off on Comfort Release® Bandages Now Available to the Public